Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 19 studies | 40% ± 12% | |
lung | 16 studies | 46% ± 13% | |
brain | 14 studies | 31% ± 17% | |
intestine | 12 studies | 28% ± 10% | |
kidney | 9 studies | 37% ± 10% | |
eye | 8 studies | 43% ± 18% | |
liver | 6 studies | 34% ± 21% | |
bone marrow | 5 studies | 26% ± 9% | |
uterus | 5 studies | 36% ± 19% | |
lymph node | 5 studies | 46% ± 24% | |
pancreas | 4 studies | 59% ± 27% | |
placenta | 4 studies | 43% ± 15% | |
prostate | 4 studies | 28% ± 8% | |
breast | 4 studies | 39% ± 3% | |
adipose | 3 studies | 23% ± 8% | |
adrenal gland | 3 studies | 35% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3792.87 | 1445 / 1445 | 100% | 100.83 | 183 / 183 |
liver | 100% | 4304.55 | 226 / 226 | 100% | 118.05 | 406 / 406 |
ovary | 100% | 2667.54 | 180 / 180 | 100% | 163.28 | 430 / 430 |
pancreas | 100% | 4522.83 | 328 / 328 | 100% | 132.73 | 178 / 178 |
skin | 100% | 4344.77 | 1809 / 1809 | 100% | 169.93 | 472 / 472 |
uterus | 100% | 3196.26 | 170 / 170 | 100% | 155.14 | 459 / 459 |
thymus | 100% | 5686.61 | 653 / 653 | 100% | 122.49 | 604 / 605 |
brain | 100% | 6110.02 | 2637 / 2642 | 100% | 135.04 | 705 / 705 |
prostate | 100% | 5236.28 | 245 / 245 | 100% | 192.38 | 501 / 502 |
stomach | 100% | 4616.25 | 359 / 359 | 100% | 123.10 | 285 / 286 |
breast | 100% | 3873.71 | 459 / 459 | 100% | 162.22 | 1114 / 1118 |
intestine | 100% | 4201.57 | 966 / 966 | 100% | 138.07 | 525 / 527 |
adrenal gland | 100% | 7271.51 | 258 / 258 | 100% | 163.69 | 229 / 230 |
kidney | 100% | 9607.33 | 89 / 89 | 99% | 111.82 | 896 / 901 |
lung | 100% | 6411.26 | 578 / 578 | 99% | 131.84 | 1148 / 1155 |
bladder | 100% | 3598.57 | 21 / 21 | 99% | 155.92 | 498 / 504 |
eye | 0% | 0 | 0 / 0 | 100% | 120.41 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 161.69 | 29 / 29 |
peripheral blood | 100% | 13521.44 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 7375.09 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 129.62 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 225.22 | 1 / 1 |
adipose | 100% | 3654.19 | 1202 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 3775.95 | 799 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 3447.74 | 1326 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 3025.46 | 844 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0048388 | Biological process | endosomal lumen acidification |
GO_0007042 | Biological process | lysosomal lumen acidification |
GO_0051452 | Biological process | intracellular pH reduction |
GO_0007035 | Biological process | vacuolar acidification |
GO_0061795 | Biological process | Golgi lumen acidification |
GO_0016241 | Biological process | regulation of macroautophagy |
GO_1902600 | Biological process | proton transmembrane transport |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_1902495 | Cellular component | transmembrane transporter complex |
GO_0033176 | Cellular component | proton-transporting V-type ATPase complex |
GO_0000139 | Cellular component | Golgi membrane |
GO_0030670 | Cellular component | phagocytic vesicle membrane |
GO_0000220 | Cellular component | vacuolar proton-transporting V-type ATPase, V0 domain |
GO_0010008 | Cellular component | endosome membrane |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0030665 | Cellular component | clathrin-coated vesicle membrane |
GO_0046961 | Molecular function | proton-transporting ATPase activity, rotational mechanism |
GO_0005515 | Molecular function | protein binding |
Gene name | ATP6V0B |
Protein name | ATPase H+ transporting V0 subunit b V-type proton ATPase 21 kDa proteolipid subunit c'' (V-ATPase 21 kDa proteolipid subunit c'') (Vacuolar proton pump 21 kDa proteolipid subunit c'') (hATPL) |
Synonyms | ATP6F |
Description | FUNCTION: Proton-conducting pore forming subunit of the V0 complex of vacuolar(H+)-ATPase (V-ATPase), a multisubunit enzyme composed of a peripheral complex (V1) that hydrolyzes ATP and a membrane integral complex (V0) that translocates protons . V-ATPase is responsible for acidifying and maintaining the pH of intracellular compartments and in some cell types, is targeted to the plasma membrane, where it is responsible for acidifying the extracellular environment (By similarity). . FUNCTION: Proton-conducting pore forming of the V0 complex of vacuolar(H+)-ATPase (V-ATPase), a multisubunit enzyme composed of a peripheral complex (V1) that hydrolyzes ATP and a membrane integral complex (V0) that translocates protons. V-ATPase is responsible for acidifying and maintaining the pH of intracellular compartments and in some cell types, is targeted to the plasma membrane, where it is responsible for acidifying the extracellular environment. . FUNCTION: Proton-conducting pore forming of the V0 complex of vacuolar(H+)-ATPase (V-ATPase), a multisubunit enzyme composed of a peripheral complex (V1) that hydrolyzes ATP and a membrane integral complex (V0) that translocates protons. V-ATPase is responsible for acidifying and maintaining the pH of intracellular compartments and in some cell types, is targeted to the plasma membrane, where it is responsible for acidifying the extracellular environment. . |
Accessions | ENST00000471859.6 ENST00000498664.1 [Q99437-2] ENST00000236067.8 [Q99437-2] Q99437 ENST00000461670.5 E9PMR1 ENST00000498208.1 ENST00000532642.5 E9PNU0 H0YCC5 E9PKB6 ENST00000472505.6 ENST00000472174.7 [Q99437-1] E9PNL3 |